De novo multiple endocrine neoplasia type 2B with noncardiogenic pulmonary edema as the presenting symptom

Endocrine Journal

Volumn 53, Issue 4, 2006, Pages 523-529

  Sato, Haruhiro ^a   Suzuki, Yasuhiro ^a   Fukasawa, Maki ^a   Yasuda, Masanori ^a   Osamura, Robert Yoshiyuki ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

De novo; Multiple endocrine neoplasia 2B; Noncardiogenic pulmonary edema

Indexed keywords

CALCITONIN; CARCINOEMBRYONIC ANTIGEN; CATECHOLAMINE DERIVATIVE; DILTIAZEM; DOXAZOSIN MESYLATE; IMIPENEM; METHIONINE; PARATHYROID HORMONE; THREONINE;

ADRENAL TUMOR; ADRENALECTOMY; ADULT; AMINO ACID SUBSTITUTION; ANAMNESIS; ARM; ARTICLE; ARTIFICIAL VENTILATION; BODY HEIGHT; BODY WEIGHT; CASE REPORT; CODON; COLON BIOPSY; COMPUTER ASSISTED TOMOGRAPHY; CONSTIPATION; ECHOGRAPHY; EXON; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; HYPERTENSION; HYPOXEMIA; INTUBATION; LABORATORY TEST; LAPAROSCOPIC SURGERY; LIP; MALE; MULTIPLE ENDOCRINE NEOPLASIA; NEUROMA; NONCARDIOGENIC LUNG EDEMA; PARENT; PHEOCHROMOCYTOMA; SYMPTOM; THYROIDECTOMY; TONGUE TUMOR; TOXIC MEGACOLON; WILD TYPE;

ADRENAL GLAND NEOPLASMS; ADULT; BASE SEQUENCE; CARCINOMA, MEDULLARY; HUMANS; MALE; MOLECULAR SEQUENCE DATA; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B; PULMONARY EDEMA; THYROID NEOPLASMS;

EID: 33748440756     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K06-007     Document Type: Article

References (21)

1. Eng C, Clayton D, Schuffenecker I, Lenoir G, Cote G, Gagel RF, van Amstel HKP, Lips CJM, Nishino I, Takai S, Marsh DJ, Robinson BG, Frank-Raue K, Raue F, Xue F, Noll WW, Romei C, Pacini C, Pacini F, Fink M, Niederle B, Zedenius J, Nordenskjöld M, Komminoth P, Hendy GN (1996) The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. J Am Med Assoc 276: 1575-1579.
2. Carlson KM, Bracamontes J, Jackson CE, Clark R, Lacroix A, Wells SA Jr, Goodfellow PJ (1994) Parent-of-origin effects in multiple endocrine neoplasia type 2B. Am J Hum Gen 55: 1076-1082.
3. Vasen HF, van der Feltz M, Raue F, Kruseman AN, Koppeschaar HP, Pieters G, Seif FJ, Blum WF, Lips CJ (1992) The natural course of multiple endocrine neoplasia type 2b. Arch Int Med 152: 1250-1252.
4. Sanso GE, Domene HM, Garcia R, Pusiol E, de Mondino AK, Roque M, Ring A, Perinetti H, Elsner B, Iorcansky S, Barontini M (2002) Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers. Cancer 94: 323-330.
5. de Leeuw PW, Waltman FL, Birkenhager WH (1986) Noncardiogenic pulmonary edema as the sole manifestation of pheochromocytoma. Hypertension 8: 810-812.
6. Naeije R, Yarnault JC, Goldstein M, Corhil A (1987) Acute pulmonary oedema in patient with phaeochromocytoma. Intensive Care Med 4: 165-167.
7. Van Vliet PD, Burchell HB, Titus JL (1966) Focal myocarditis associated with pheochromocytoma. New Engl J Med 274: 1102-1108.
8. Yankopoulos NA, Montero AC, Curd WG Jr, Kahil ME, Condon RE (1974) Observations on myocardial function during chronic catecholamine over secretion: a young patient with pheochromocytoma. Chest 66: 585-587.
9. Berk JL, Hagen JF, Koo R, Beyer W, Dochat GR, Rupright M, Nomoto S (1973) Pulmonary insufficiency caused by epinephrine. Ann Surg 178: 423-435.
10. Rosner MJ, Newsome HH, Becker DP (1984) Mechanical brain injury: the sympathoadrenal response. J Neurosurg 61: 76-86.
11. Theodore J, Robin ED (1975) Pathogenesis of neurogenic pulmonary oedema. Lancet 7938: 749-751.
12. Sweeney AT, Malabanan AO, Blake MA, de las Morenas A, Cachecho R, Melby JC (2000) Megacolon as the presenting feature in pheochromocytoma. J Clin Endocrinol Metab 85: 3968-3972.
13. Friedman PA, Gesek FA (1995) Cellular calcium transport in renal epithelia: measurement, mechanisms and regulation. Physiol Rev 75: 429-471.
14. Chambers TJ, McSheehy PM, Thomson BM, Fuller K (1985) The effect of calcium-regulating hormones and prostaglandins on bone resorption by osteoclasts disaggregated from neonatal rabbit bones. Endocrinology 116: 234-239.
15. Bhatnagar D, Carey P, Pollard A (1986) Focal myositis and elevated creatinine kinase levels in a patient with pheochromocytoma. Postgrad Med J 62: 197-198.
16. Yamanishi J, Nishikawa M, Ohomori Y, Furuta Y, Fukuzaki H (1985) Pheochromocytoma with transient hyperamylasaemia during hypertensive crisis. Br Med J 291: 1171.
17. Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, Conte-Devolx B, Falchetti A, Gheri RG, Libroia A, Lips CJ, Lombardi G, Mannelli M, Pacini F, Ponder BA, Raue F, Skogseid B, Tamburrano G, Thakker RV, Thompson NW, Tomassetti P, Tonelli F, Wells SA Jr, Marx SJ (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86: 5658-5671.
18. van Heerden JA, Grant CS, Gharib H, Hay ID, Ilstrup DM (1990) Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma. Ann Surg 212: 395-400.
19. Kebebew E, Ituarte PH, Siperstein AE, Duh QY, Clark OH (2000) Medullary thyroid carcinoma. Clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer 88: 1139-1148.
20. Kameyama K, Takami H (2004) Medullary thyroid carcinoma: nationwide Japanese survey of 634 cases in 1996 and 271 cases in 2002. Endocr J 51: 453-456.
21. Shigematsu N, Takami H, Ito N, Kubo A (2005) Nationwide survey on the treatment policy for well-differentiated thyroid cancer. Endocr J 52: 479-491.